Patients’ Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment
The Patient - Patient-Centered Outcomes Research · 2024
DOI: 10.1007/s40271-024-00699-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Patient - Patient-Centered Outcomes Research, 2024. Verfasst von Alexander Keenan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Janssen Scientific Affairs, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA. akeenan1@its.jnj.com. Hauptthemen laut MEDLINE: Patient Preference, Sphingosine 1 Phosphate Receptor Modulators, Multiple Sclerosis, Relapsing-Remitting, Fingolimod Hydrochloride. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Janssen Pharmaceuticals.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Janssen Scientific Affairs, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA. akeenan1@its.jnj.com.
- Evidera, The Ark, 201 Talgarth Rd, London, W6 8BJ, UK.
- Janssen Scientific Affairs, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA.
- Janssen Research and Development, 800 Ridgeview Drive, Horsham, PA, 19044, USA.
- Evidera, 7101 Wisconsin Ave # 1400, Bethesda, MD, 20814, USA.
- Loyola University Chicago, 2160 S 1st Ave, Maywood, IL, 60153, USA.
ORCID-Profile: Chiara Whichello
Förderung
- Janssen Pharmaceuticals
Zitieren
APA
Keenan, A., Whichello, C., Le, H. H., Kern, D. M., Fernandez, G. S., Turner, V., Das, A., Quaife, M., & Ross, A. P. (2024). Patients’ Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment. The Patient - Patient-Centered Outcomes Research. https://doi.org/10.1007/s40271-024-00699-2
Vancouver
Keenan A, Whichello C, Le HH, Kern DM, Fernandez GS, Turner V, et al. Patients’ Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment. The Patient - Patient-Centered Outcomes Research. 2024. doi:10.1007/s40271-024-00699-2
BibTeX
@article{Keenan2024,
author = {Keenan, Alexander and Whichello, Chiara and Le, Hoa H and Kern, David M and Fernandez, Gabriela S and Turner, Vicky and Das, Anup and Quaife, Matthew and Ross, Amy Perrin},
title = {Patients’ Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment},
journal = {The Patient - Patient-Centered Outcomes Research},
year = {2024},
doi = {10.1007/s40271-024-00699-2}
}
EUVIMED